Hemorrhoid Drugs Market Size & Share, by Drug Type (Topical Steroids, Topical Anesthetics); Disease Type (Internal Hemorrhoids, External Hemorrhoids); Distribution Channel (Online, Offline); End-user (Hospitals, Home Care, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3057
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Hemorrhoid Drugs Market size is likely to expand at significant growth rate during the forecast period i.e., between 2024-2036. 

The market’s growth is influenced by the increasing cases of hemorrhoids backed by various factors such as increasing prevalence of lifestyle-based diseases, lack of physical exercise, obesity, increasing alcohol consumption, low fiber intake in diet, and growing demand for treatment options. According to the World Health Organization statistics, over 38 million children, below the age of 5 were suffering from obesity in 2019. In fact, the number of obese people globally, has tripled since 1975. Increasing number of obese people is, in turn, expected to increase the prevalence of hemorrhoid, which is projected to positively influence the market growth. Moreover, rising prominence of lifestyle diseases, such as diabetes, and hypertension, is anticipated to elevate the number of people suffering from piles. According to another data by the WHO, over 422 million people around the globe suffer from diabetes, and it causes about 1.6 million deaths every year. On account of these factors, the demand for hemorrhoid drugs is anticipated to increase over the forecast period. 


Global-Hemorrhoid-Drugs-Market-Overview
Get more information on this report: Request Free Sample PDF

Hemorrhoid Drugs Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Prevalence of Lifestyle-Based Health Problems
  • Growing Cases of Chronic Constipation among the Individuals
  • Poor Eating Habits, Especially among Older Individuals

Challenges

  • The high cost of over-the-counter drugs
  • Feeling of Embarrassment and Social Shame
  • Increasing Popularity of Home Remedies for Treating Piles

Hemorrhoid Drugs Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Hemorrhoid Drugs Segmentation

The global hemorrhoid drugs market is segmented by end-user into hospitals, home care, specialty clinics, and others, out of which, the hospitals segment is anticipated to hold the largest share over the forecast period owing to the complications associated with the disease. The homecare segment is also estimated to witness significant growth by the end of 2036, owing to the increasing acceptance of homecare for the older patients. On the basis of disease type, the external hemorrhoids segment is anticipated to garner major market share over the forecast period, owing to the use of drugs as a treatment approach for external hemorrhoids, whereas, surgery is preferred for internal hemorrhoids.

Our in-depth analysis of the global market includes the following segments

By Drug Type

  • Topical Steroid
  • Topical Anesthetics
  • Others

By Disease Type

  • Internal Hemorrhoids
  • External Hemorrhoids

By Distribution Channel

 

  • Offline
  • Online

By End User

 

  • Hospitals
  • Home Care
  • Specialty Clinics
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Hemorrhoid Drugs Industry - Regional Synopsis

Regionally, the global hemorrhoid drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

Europe Market Statistics

Europe industry is expected to dominate majority revenue share by 2036, on the back of high geriatric population, coupled with availability of advanced treatment options, better reimbursement policies and fast commercialization of novel products. The EU includes 27 countries, including France, Belgium, Germany, and Luxemburg among others. Moreover, presence of well-established healthcare infrastructure and high disposable income in the region are anticipated to propel the growth of the hemorrhoid drugs market in the region.

APAC Market Analysis

The hemorrhoid drugs market in the Asia Pacific is estimated to witness the highest CAGR during the forecast period, owing to the increasing population, growing healthcare sector, and emerging pharmaceutical companies.

Research Nester
Global-Hemorrhoid-Drugs-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Hemorrhoid Drugs Landscape

    • Aytu Consumer Health, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Takeda Consumer Healthcare Company (Arinamin Pharmaceutical Co., Ltd.)
    • Taro Pharmaceutical Industries Ltd.
    • AstraZeneca plc
    • The Himalaya Drug Company  
    • Panacea Biotec Ltd.
    • Abbott Laboratories
    • Sanofi-aventis Groupe
    • Pfizer Inc.
    • Purdue Pharma L.P.

Author Credits:  Radhika Pawar


  • Report ID: 3057
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of piles or hemorrhoids on the back of poor diet, lifestyle diseases and obesity, is the major factor driving the market growth.

The market is anticipated to attain a robust CAGR over the forecast period, i.e., 2021-2029.

Social shame and stigma related to hemorrhoids is a major factor estimated to hamper the market growth.

The market in Europe will provide the highest growth opportunities for the market during the forecast period on the back of increasing geriatric population and improving healthcare sector.

The major players in the market are Taro Pharmaceutical Industries Ltd., AstraZeneca, The Himalaya Drug Company, Panacea Biotec Ltd., Abbott Healthcare Private Limited, Sanofi-aventis Groupe, Pfizer Inc., Purdue Pharma L.P and others.
Hemorrhoid Drugs Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample